Reprofiling analysis of FDA approved drugs with upregulated differential expression genes found in hypertension
Background: Hypertension is one of the most devastating human health problems with a higher incidence of both mortality and morbidity. The prevalence of this disease is more pronounced in underdeveloped countries as compared to developed countries. Drug discovery and development is a complex, time-c...
Main Authors: | Fawad Ali, He Liu Fang, Fawad Ali Shah, Syed Aun Muhammad, Arifullah Khan, Shupeng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Informatics in Medicine Unlocked |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914822000478 |
Similar Items
-
NF-κB Inhibitors Attenuate MCAO Induced Neurodegeneration and Oxidative Stress—A Reprofiling Approach
by: Awais Ali, et al.
Published: (2020-03-01) -
METHODS OF SELECTING THE EFFECTIVE MODELS OF BUILDINGS REPROFILING PROJECTS
by: Александр Иванович МЕНЕЙЛЮК, et al.
Published: (2016-02-01) -
Quantitative Real-Time Analysis of Differentially Expressed Genes in Peripheral Blood Samples of Hypertension Patients
by: Fawad Ali, et al.
Published: (2022-01-01) -
Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor.
by: Vasudevan, SR, et al.
Published: (2012) -
Drug Repurposing Approaches to Combating Viral Infections
by: Jay Trivedi, et al.
Published: (2020-11-01)